1-(Tert-butoxycarbonyl)-4,4-dimethylpiperidine-2-carboxylic acid, 98%, 250mg

METHYL 2-FLUORO-3-CYANOBENZOATE, 95.0%, 1g

3-Methylisonicotinaldehyde, 95.0%, 250mg

(R)-1,1,1-Trifluoro-2-propylamine, 99.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(5-fluoro-1H-indol-3-yl)propanoic acid, 98.0%, 250mg

6-Methyl-3H-thieno[2,3-d]pyrimidin-4-one, 95.0%, 10g

BENZYL (4-(DIMETHOXYMETHYL)PYRIMIDIN-2-YL)CARBAMATE, 95.0%, 500mg

Methyl 5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazole-4-carboxylate, 98%, 5g

(R)-1,4-Dibenzyl-2-(chloromethyl)piperazine, 98%, 100mg

Phenazine-1,6-dicarboxylic acid, 95%, 100mg

Matraces aforados clase A Vidrio transparente, 10 ml, 7/16, 2 unidad(es), 2 Pieza(s)

3',4'-Dichloro-[1,1'-biphenyl]-4-amine, 95%, 5g

4-{[(propan-2-yl)amino]methyl}phenol hydrochloride, 95.0%, 10g